The anti-tumour properties and biodistribution (as determined by the radiolabeled equivalent) of Au-compounds intended as potential chemotherapeutics

Applied Radiation and Isotopes

Volumn 67, Issue 7-8, 2009, Pages 1370-1376

  Nell, M J ^a   Wagener, J M ^b   Zeevaart, J R ^c   Kilian, E ^a   Mamo, M A ^d   Layh, M ^d   Coyanis, M ^e   van Rensburg, C E J ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NECSA   (South Africa)

^c NORTH WEST UNIVERSITY   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e MINTEK   (South Africa)

Author keywords

Anti tumour activity; Au compounds; Biodistribution; Radioactive tracers

Indexed keywords

ANTI-TUMOUR ACTIVITY; AU-COMPOUNDS; BIODISTRIBUTION; CANCER CELLS; CHEMOTHERAPEUTIC DRUGS; CLINICAL STUDY; HYDROPHILIC DRUGS; IN-CELL; IN-VITRO; LIPOPHILIC DRUGS; OCTANOL/WATER PARTITION COEFFICIENT; PHOSPHINE COMPLEX; TOTAL UPTAKE;

ALCOHOLS; CELL MEMBRANES; GOLD COMPOUNDS; GROWTH KINETICS; PHOSPHORUS COMPOUNDS; RADIOACTIVE TRACERS; RADIOACTIVITY; RADIOISOTOPES; TOXICITY;

TUMORS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDROPHOBICITY; ORGANOGOLD COMPOUNDS; PHOSPHINES; TISSUE DISTRIBUTION;

EID: 67349163241     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.02.035     Document Type: Article

References (19)

1. Anderson R., Smit M.J., and van Rensburg C.E.J. Lysophospholipid-mediated inhibition of Na, K-adenosine triphosphatase is a possible mechanism of immunorepressive activity of cyclosporin A. Mol. Pharmacol. 44 (1993) 605-619
2. Berners-Price S.J., Mirabelli C.K., Johnson R.K., Mattern M.R., McCabe F.L., Faucette L.F., Sung C.-M., Mong S.-M., Sadler P.J., and Crooke S.T. In vivo anti-tumor activity and in vitro cytotoxic properties of Bis [1, 2-bis(diphenyl phosphino)ethane]gold(I)chloride. Cancer Res. 46 (1986) 5486-5493
3. Berners-Price S.J., Bowen R.J., Galettis P., Healy P.C., and McKeage M.J. Structural and solution of gold(I) and silver(I) complexes of bidentate pyridyl phosphines: selective anti-tumor agents. Coord. Chem. Rev. 186 (1999) 823-836
4. Berners-Price S.J., and Sadler P.J. Gold(I) complexes with bidentate tertiary phosphine ligands: formation of annular vs. tetrahedral chelated complexes. Inorg. Chem. 25 (1986) 3822-3827
5. Bowen, R.J., 1999. Hydrophilic bidentate phosphines and their group 11 complexes: potential anti-tumour agents. Ph.D. Thesis, Griffith University, Australia, 112.
6. Caruso F., Villa R.V., Rossi M., Pettinari C., Paduano F., Pennati M., Daidone M.G., and Zaffaroni N. Mitochondria are primary targets in apoptosis induced by the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I) in melanoma cell lines. Biochem. Pharmacol. 73 (2007) 773-781
7. Cossarizza A., Baccarani-Contri M., Kalashnikova G., and Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′tetrachloro-1,1′,3,3′-tetraethylbenzimi dazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197 1 (1993) 40-45
8. Debatin K.M., Poncet D., and Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 12 57 (2002) 8786-8803
9. Freshney R.I. Culture of Animal Cells: A Manual of Basic Technique. fourth ed (2000), Wiley-Liss Publishers, New York
10. Frühauf N.R., Oldhafer K.J., Höltje M., Kaiser G.M., Frühauf J.H., Stavrou G.A., Bader A., and Broelsch C.E. A bio artificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surgery 136 (2004) 47-56
11. Hoke G.D., Rush G.F., Bossard G.E., McArdle J.V., Jensen B.D., and Mirabelli C.K. Mechanism of alterations in isolated rat liver mitochondrial function induced by gold complexes of bidentate phosphines. J. Biol. Chem. 263 23 (1988) 11203-11210
12. Hoke G.D., McCabe F.L., Faucette L.F., O'Leary Bartus J., Sung C.-M., Jensen B.D., Heys R., Rush G.F., Alberts D.W., Johnson R.K., and Mirabelli C.K. In vivo development and in vitro characterization of a subclone of Murine P388 Leukemia resistant to bis(diphenylphosphine)ethane. Mol. Pharmacol. 39 1 (1991) 90-97
13. Mahepal, S., Bowen, R., Mamo, M.A., Layh, M., Jansen van Rensburg, C.E., 2008. The in vitro antitumour activity of novel, mitochondrial-interactive, gold-based lipophilic cations. Met. Based Drugs. 2008, doi:10.1155/2008/864653 (Article ID 864653, 5 pages).
14. Michie J., Akudugu J., Binder A., Van Rensburg C.E.J., and Böhm L. Flow cytometric evaluation of apoptosis and cell viability as a criterion of anti-tumour drug toxicity. Cancer Res. 56 (2003) 544-550
15. Modica-Napolitano J.S., and Aprille J.R. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug Delivery Rev. 49 1-2 (2001) 63-70
16. Nieuwoudt M.J., Kreft E., Olivier B., Malfeld S., Vosloo J., Stegman F., Kunneke R., Van Wyk A.J., and Van der Merwe S.W. A large-scale automated method for hepatocyte isolation: effects on proliferation in culture. Cell Transpl. 14 5 (2005) 291-299
17. Smith P.F., Hoke G.D., Alberts D.W., Bugelski P.J., Lupo S., Mirabelli C.K., and Rush G.F. Mechanism of toxicity of an experimental bidentate phosphine gold complexed anti-neoplastic agent in isolated rat hepatocytes. Pharmacol. Exp. Ther. 249 3 (1989) 944-950
18. Tsuruo T., Iida H., Tsukagoshi S., and Sakurai Y. Increased accumulation of Vincristine and Adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 42 (1982) 4730-4733
19. Tuschl H., and Schwab C.E. Flow cytometric methods used as screening tests for basal toxicity of chemicals. Toxicol. in vitro 18 (2004) 483-491